ESCO2 and hepatocellular carcinoma: Consistent with the results of bulk RNA sequencing data analysis, cell proliferation-associated pathways, such as E2F targets, G2M checkpoint, and MYC targets signaling, were significantly enriched in ESCO2-positive hepatoma cells.